UBS AM’s Omega Healthcare OHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$101M Sell
2,114,655
-10,743
-0.5% -$498K 0.02% 514
2026
Q1
$93.1M Buy
2,125,398
+17,238
+0.8% +$787K 0.02% 524
2025
Q4
$93.5M Buy
+2,108,160
New +$90.8M 0.02% 507
2025
Q3
Sell
-2,785,809
Closed -$102M 2495
2025
Q2
$102M Buy
2,785,809
+2,407,795
+637% +$89.4M 0.02% 533
2025
Q1
$14.4M Sell
378,014
-1,459,718
-79% -$54.3M ﹤0.01% 1086
2024
Q4
$69.6M Buy
1,837,732
+175,768
+11% +$7.02M 0.02% 594
2024
Q3
$67.6M Buy
1,661,964
+1,274,238
+329% +$48.2M 0.02% 605
2024
Q2
$13.3M Sell
387,726
-970,399
-71% -$30.6M ﹤0.01% 1019
2024
Q1
$43M Sell
1,358,125
-106,977
-7% -$3.25M 0.02% 636
2023
Q4
$44.9M Buy
1,465,102
+202,029
+16% +$6.48M 0.02% 616
2023
Q3
$41.9M Buy
1,263,073
+45,727
+4% +$1.46M 0.02% 606
2023
Q2
$33.4M Hold
1,217,346
0.02% 657
2023
Q1
$33.4M Buy
1,217,346
+11,193
+0.9% +$311K 0.02% 657
2022
Q4
$33.7M Buy
1,206,153
+24,366
+2% +$735K 0.02% 639
2022
Q3
$34.9M Sell
1,181,787
-79,251
-6% -$2.48M 0.02% 630
2022
Q2
$35.5M Sell
1,261,038
-102,493
-8% -$2.92M 0.02% 621
2022
Q1
$42.5M Buy
1,363,531
+39,640
+3% +$1.17M 0.02% 651
2021
Q4
$39.2M Sell
1,323,891
-269,055
-17% -$7.86M 0.02% 714
2021
Q3
$47.7M Sell
1,592,946
-12,420
-0.8% -$427K 0.02% 627
2021
Q2
$58.3M Sell
1,605,366
-91,743
-5% -$3.41M 0.02% 605
2021
Q1
$62.2M Buy
1,697,109
+38,695
+2% +$1.42M 0.03% 570
2020
Q4
$60.2M Buy
1,658,414
+208,160
+14% +$7.05M 0.03% 549
2020
Q3
$43.4M Buy
1,450,254
+126,026
+10% +$3.93M 0.02% 572
2020
Q2
$39.4M Sell
1,324,228
-602,867
-31% -$17.9M 0.02% 564
2020
Q1
$51.1M Buy
1,927,095
+756,599
+65% +$28.7M 0.04% 430
2019
Q4
$49.6M Buy
1,170,496
+426,665
+57% +$18.1M 0.03% 536
2019
Q3
$31.1M Buy
743,831
+78,485
+12% +$3.06M 0.02% 652
2019
Q2
$24.5M Sell
665,346
-5,197
-0.8% -$189K 0.02% 712
2019
Q1
$25.6M Buy
670,543
+27,254
+4% +$1.01M 0.02% 679
2018
Q4
$22.6M Sell
643,289
-5,397
-0.8% -$187K 0.02% 681
2018
Q3
$21.3M Buy
648,686
+30,278
+5% +$964K 0.02% 738
2018
Q2
$19.2M Sell
618,408
-10,978
-2% -$314K 0.01% 780
2018
Q1
$17M Buy
629,386
+116,050
+23% +$3.09M 0.01% 795
2017
Q4
$14.1M Buy
513,336
+51,650
+11% +$1.49M 0.01% 830
2017
Q3
$14.7M Buy
461,686
+42,535
+10% +$1.36M 0.01% 813
2017
Q2
$13.8M Buy
419,151
+51,731
+14% +$1.71M 0.01% 841
2017
Q1
$12.1M Buy
367,420
+62,968
+21% +$2.02M 0.01% 855
2016
Q4
$9.52M Sell
304,452
-130,709
-30% -$4.03M 0.01% 873
2016
Q3
$15.4M Buy
435,161
+133,319
+44% +$4.74M 0.02% 769
2016
Q2
$10.2M Buy
301,842
+15,804
+6% +$527K 0.01% 876
2016
Q1
$10.1M Sell
286,038
-85,310
-23% -$2.79M 0.01% 844
2015
Q4
$13M Buy
371,348
+38,955
+12% +$1.35M 0.01% 804
2015
Q3
$11.7M Buy
332,393
+42,711
+15% +$1.5M 0.01% 833
2015
Q2
$9.95M Buy
289,682
+70,104
+32% +$2.57M 0.01% 887
2015
Q1
$8.91M Buy
219,578
+18,829
+9% +$780K 0.01% 911
2014
Q4
$7.84M Buy
200,749
+10,157
+5% +$385K 0.01% 935
2014
Q3
$6.52M Sell
190,592
-7,700
-4% -$283K 0.01% 978
2014
Q2
$7.31M Buy
198,292
+7,500
+4% +$268K 0.01% 944
2014
Q1
$6.39M Buy
190,792
+25,018
+15% +$797K 0.01% 976
2013
Q4
$4.94M Sell
165,774
-15,151
-8% -$480K 0.01% 1011
2013
Q3
$5.4M Sell
180,925
-11,800
-6% -$359K 0.01% 967
2013
Q2
$5.98M Buy
+192,725
New +$6.33M 0.01% 915

Other funds holding OHI

UBS AM's OHI Position: Q2 2026 in Review

UBS AM reduced its Omega Healthcare (OHI) stake by 0.51% in Q2 2026, selling an estimated $498K and leaving 2,114,655 shares worth $101M. The position accounts for 0.02% of the portfolio, ranked #514.

UBS AM first reported a position in OHI in Q2 2013 and has held it in 52 quarters since. The position peaked at $102M in Q2 2025. 756 funds tracked by Wall St. Rank hold OHI as of Q2 2026.

  • UBS AM held 2,114,655 shares of Omega Healthcare worth $101M as of Q2 2026.
  • UBS AM sold 10,743 Omega Healthcare shares in Q2 2026, an estimated $498K.
  • Omega Healthcare made up 0.02% of UBS AM's portfolio in Q2 2026, its #514 holding.
  • UBS AM first reported a position in Omega Healthcare in Q2 2013 and has held it in 52 quarters since.
  • UBS AM's Omega Healthcare position peaked at $102M in Q2 2025.
  • 756 funds tracked by Wall St. Rank held Omega Healthcare as of Q2 2026.

Based on UBS AM's 13F filing for Q2 2026, filed 13 Aug 2026.